Showing results (191-200 of 250) with videos related to

Sort By:
Pageof 25
Molecular Neurodegeneration|August 11, 2021
Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosisLaura Pasetto, Stefano Callegaro, Alessandro Corbelli, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 25, 2017
Trauma and amyotrophic lateral sclerosis: a european population-based case-control study from the EURALS consortiumElisabetta Pupillo, Marco Poloni, Elisa Bianchi, et al.
European Journal of Neurology|December 10, 2024
Sex-related differences in amyotrophic lateral sclerosis: A 2-[18F]FDG-PET studyAntonio Canosa, Alessio Martino, Umberto Manera, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 17, 2016
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosisCecilia Marini, Angelina Cistaro, Cristina Campi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 14, 2020
Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experienceRosario Vasta, Cristina Moglia, Fabrizio D'Ovidio, et al.
Archives of Neurology|January 12, 2011
Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP geneAdriano Chiò, Giuseppe Borghero, Maura Pugliatti, et al.
Annals of Neurology|February 20, 2025
Brain Metabolic Features of FUS-ALS: A 2-[18F]FDG-PET StudyAntonio Canosa, Umberto Manera, Rosario Vasta, et al.
Annals of Clinical and Translational Neurology|April 25, 2025
KIF5A p.Pro986Leu Risk Variant and Accelerated Progression of Amyotrophic Lateral SclerosisArianna Manini, Rosario Vasta, Alberto Brusati, et al.
Neurobiology of Aging|July 26, 2015
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestryGiuseppe Borghero, Maura Pugliatti, Francesco Marrosu, et al.
Pageof 25